SHAREHOLDERS' EQUITY AND SHARE-BASED COMPENSATION (Tables)

12 Months Ended

Dec. 31, 2022

Share-Based Payment Arrangement [Abstract]

Schedule of assumptions used to determine the fair value of options as of the grant date

The following assumptions were used to determine the fair values as of the grant date for the year ended December 31,:

	2022
	Black-Scholes
Risk-free interest rate (%)	1.62 - 4.20
Expected stock price volatility (%)	67.75 - 67.99
Expected dividend yield	—
Expected option life (in years)	6
Fair value	$7.27 - $7.63

Summary of the weighted average fair value of stock options granted, the total intrinsic value of stock options exercised and the fair value of options vested

The following table summarizes the weighted average grant date fair value of stock options granted per share, the total intrinsic value of stock options exercised and the grant date fair value of stock options that vested during the years ended December 31:

(in thousands, except per share data)	2022		2021
Weighted average grant date fair value of stock options granted per share	$	8.25	$	—
Intrinsic value of options exercised	—		—
Grant date fair value of stock options that vested	$	1,031	$	1,203

Summary of the activity of the entity's stock options

The following table summarizes the activity related to our stock options:

	Number of options	Weighted average exercise price		Weighted average contractual term (in years)	Aggregate intrinsic value (in thousands)
Outstanding as of December 31, 2021	687,339	$	27.99	4.57	$	—
Granted	120,000	11.86
Forfeited	(62,062)	58.95
Outstanding as of December 31, 2022	745,277	27.03		4.83	—
Exercisable as of December 31, 2022	542,290	25.44		4.17	—

Shares authorized under stock option plans, by exercise price range

The following table summarizes information about stock options outstanding and exercisable as of December 31, 2022:

	Options outstanding				Options exercisable
Exercise price range (1)	Number	Weighted average remaining contractual life (in years)	Weighted average exercise price		Number	Weighted average remaining contractual life (in years)	Weighted average exercise price
$10.01 — $20.00	247,400	5.66	$	15.43	123,238	2.29	$	18.79
$20.01 — $30.00	413,398	4.14	24.85		388,046	4.15	24.82
$30.01 — $40.00	29,479	3.65	33.19		17,256	3.65	33.58
$80.01 — $90.00	25,000	1.60	86.69		6,250	1.60	86.69
$90.01 — $100.00	30,000	1.75	96.87		7,500	1.75	96.87
	745,277				542,290
______________________________________
(1) These options contain market-based and performance-based components as described above.

Shares authorized under stock option plans by vesting price range

The following table summarizes the market prices necessary in order for the market-based options to begin to vest:

	Market-based options
Vesting price	Ordinary performance		Extraordinary performance
$50.01 — $60.00	7,581		4,162
$60.01 — $70.00	8,148		6,250
$80.01 — $90.00	—		3,791
$90.01 — $100.00	—		4,075
$170.01 — $180.00	12,500		—
Over $190.00	15,000		13,750
Total	43,229		32,028
Weighted average share price	$	69.69	$	53.74

Restricted shares and restricted share units activity

The following table summarizes the activity related to our restricted shares and restricted share units:

	Number of restricted shares and restricted share units
Outstanding as of December 31, 2021	625,638
Granted	500,631
Issued	(218,106)
Forfeited/canceled	(153,157)
Outstanding as of December 31, 2022	755,006

Fair Value of Performance-based Awards

The following assumptions were used to determine the fair values for the performance-based awards that include both a performance condition and a market condition, and fair values for market-based awards as of the grant date for the years ended December 31:

	2022		2021
	Monte Carlo	Binomial	Monte Carlo	Binomial
Risk-free interest rate (%)	1.04	—	0.16	—
Expected stock price volatility (%)	59.90	—	39.54	—
Expected dividend yield	—	—	—	—
Expected life (in years)	3	0	3	0
Fair value	$—	$—	$10.16	$—